Mediator Appointed to Oversee Settlement Negotiations in Dabigatran Lawsuits
The U.S. District Judge presiding over the Dabigatran federal MDL has appointed a mediator to meet with both sides on a monthly basis to encourage a settlement agreement. The lawsuits...
Study: Low Heart Rate While Exercising May Increase AF Risk
According to information from a new Norwegian study, men who exercise and experience a low heart rate during said exercise are at an increased risk of developing atrial fibrillation (AF)...
Study Links Heart Attacks to Dabigatran Use
While the side effects linked to the use of the anticoagulant atrial fibrillation (AF) medication Dabigatran have long been discussed, a new study is showing that heart attack risks have...
Hope Not Lost in Dismissed Dabigatran Class Action
While a federal judge has decided to dismiss a class action lawsuit against the makers of Pradaxa (dabigatran), the judge is also letting the plaintiff pursue an individual lawsuit against...
New Lawsuit Filed Over Pradaxa AF Medication
The anticoagulant medication known as Pradaxa (dabigatran), which is used to treat atrial fibrillation and other heart complications, is the subject of a new lawsuit against its manufacturer, Boehringer Ingelheim....